Presentation_1_Bergenin as a Novel Urate-Lowering Therapeutic Strategy for Hyperuricemia.pdf by Mo Chen (299059)

Image_1_Bergenin as a Novel Urate-Lowering Therapeutic Strategy for Hyperuricemia.TIF by Mo Chen (299059)

Image_2_Bergenin as a Novel Urate-Lowering Therapeutic Strategy for Hyperuricemia.TIF by Mo Chen (299059)

Table_1_Bergenin as a Novel Urate-Lowering Therapeutic Strategy for Hyperuricemia.DOCX by Mo Chen (299059)

Fig 2 - by Benazir Hodzic-Santor (14593183)

Clinical features of Type 2 Diabetes (T2D) patients. by Adriana Carvalho-Santos (814114)

Clinical features of Type 1 Diabetes (T1D) patients. by Adriana Carvalho-Santos (814114)

Fig 2 - by Leila Vahdatiraad (17382718)

Bar graphs showing the total loss rates and 95% confidence intervals for each region in Ethiopia, Kenya, and Benin. by Beatrice T. Nganso (4114768)

Multinomial logistic regression analyses predicting impact on vaccination intention by demographics (more likely vs. less likely to get vaccinated comparison). by Rikki H. Sargent (12441964)

A 1,2,3-Triazole Derivative of Quinazoline Exhibits Antitumor Activity by Tethering RNF168 to SQSTM1/P62 by Fu-Cheng Wang (14059045)

“…We found that compound <b>5a</b> was the most cytotoxic to HCT-116 cells (IC₅₀, 0.36 μM). …”

Transient expression of HIF1α(PP) inhibited intracranial tumor growth. by Hyunsung Choi (727224)

“…Tumor volumes, plotted in a log scale, decreased significantly from HIF1α(PP) in reference to β-gal. …”

Morphometric analysis of nuclei and peroxisomes. by Claudia Colasante (101665)

The fasting glucose (FG) levels are weakly negatively correlated with APRIL serum levels in diabetic patients. by Adriana Carvalho-Santos (814114)

Tubulin modifications and gamma-tubulin distribution in the tegument. by Inés Guarnaschelli (18102211)

Replacement of the N-type <i>Arsenophonus</i> in <i>N</i>. <i>lugens</i> with S-type <i>Arsenophonus</i> impacts the host’s insecticide resistance. by Rui Pang (1601419)

LY5 does not inhibit growth of <i>ex vivo</i> pulmonary metastasis. by Peter Y. Yu (4281448)

The association of diabetic retinopathy with metabolic syndrome. by Lu Gao (44114)

“…When patients were grouped according to the number of detected components of the metabolic syndrome, the percentage of patients with DR increased linearly with the increasing number of components in their respective groups (14.3%, 38.9%, 49.1%, 61.4%, 83.3%, respectively), whereas, the percentage of patients without DR decreased with the increasing number of components (85.7%, 61.1%, 50.9%, 38.6%, 16.7%, respectively) (Pearson χ² = 9.938, P = 0.037). …”

Expression levels of <i>Alox15</i>, <i>Hmox1</i> and <i>Fth1</i> in pulmonary myeloid cell populations. by Emilie Pollenus (10147748)

S1 Data - by Xiaoguang Zhang (1397257)